In the consultation, we will assess your medical history, review any conditions you may have, discuss any medications you are taking, and review any past treatments you have received
Heres how PT-141 can improve the quality of life for both men and women
Plans that exclude anti-obesity drugs can still cover Zepbound under the OSA indication
The broader benefits beyond glucose control are increasingly recognised in clinical decision-making, though prescribing decisions should be individualised based on patient characteristics, comorbidities, and treatment goals
Future directions and research priorities Future research should prioritize well-controlled human intervention studies integrating GLP-1based pharmacotherapy with defined postbiotic preparations, with explicit assessment of body composition, lean mass preservation, and post-discontinuation weight trajectories